Main objective: investigate gene expression differences in nasal epithelium and sputum between eosinophilic COPD exacerbations and other subtypes.
Main objective: investigate gene expression differences in nasal epithelium and sputum between eosinophilic COPD exacerbations and other subtypes to better understand why some patients are more at risk for eosinophilic COPD exacerbations. Secondary objectives: 1. Investigate differences in microbiome composition and immunophenotyping profiles in peripheral blood per subtype. 2. Assess for clinical differences between all COPD exacerbation subtypes. 3. Assess if and how baseline meta-transcriptomics either in nasal epithelium or sputum and blood immunophenotyping can be utilized to predict COPD exacerbation subtype. 4. Determine if the microbiome in sputum and nasal epithelial material are comparable. 5. Determine if different subtypes of COPD exacerbations respond differently to standard treatment with oral prednisolone (40 mg daily) with or without antibiotics. 6. To evaluate if metabolic responses during recovery are different in patients with increased systemic inflammation compared to patients without systemic inflammation at exacerbation
Study Type
OBSERVATIONAL
Enrollment
100
University Maastricht
Maastricht, Limburg, Netherlands
NOT_YET_RECRUITINGUnivesity Medical Center Groningen
Groningen, Netherlands
RECRUITINGChange in gene expression profiles in sputum by RNA sequencing
Change in gene expression profiles in sputum between the four groups using RNA sequencing. The differences between the expression levels of transcripts (counts) will be analyzed.
Time frame: At admission and after 6-8 weeks after discharge.
Change in gene expression profiles in nasal epithelium by using RNA sequencing
Change in gene expression profilesin nasal epithelium between the four groups using RNA sequencing. The differences between the expression levels of transcripts (counts) will be analyzed.
Time frame: At admission and after 6-8 weeks after discharge.
Microbiome composition in sputum by using RNA sequencing.
Differences in microbiome composition in sputum between the four groups by using RNA sequencing.
Time frame: At admission, at day 5 of admission and 6-8 weeks after discharge.
Phenotype blood cell population by flow cytometry.
Differences in blood cell population between the four groups as measured by flow cytometry.
Time frame: At admission, at day 5 of admission and 6-8 weeks after discharge.
Phenotypic analysis of the T cell compartment by staining of whole blood or isolated peripheral blood mononuclear cells using antibodies
Differences in the T cell compartment between the four groups by staining of whole blood or isolated peripheral blood mononuclear cells using antibodies.
Time frame: At admission, at day 5 of admission and 6-8 weeks after discharge.
Comparison of microbiome composition in sputum and nasal epithelial material by RNA sequencing.
Measure microbiome composition in sputum and nasal epithelium by RNA sequencing. Compare them by the bacterial taxa which are significantly different between groups
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: At admission and 6-8 weeks after discharge.
Clinical differences between groups by the COPD Assessment Test (CAT).
Differences in number of participants per group with a high impact of COPD related symptoms as assessed by the CAT.
Time frame: Every day of hospital admission.
Clinical differences between groups by peak flow measurements.
Differences in number of participants per group with a low peak expiratory flow rate as measured by a handheld peak flow meter.
Time frame: Every day of hospital admission.